• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 98 of 100
Flu Outbreak Continues In Bay Area
RetailIt’s a bad flu season, but that’s good news for Walgreen
By Laura LorenzettiJanuary 6, 2015
Picture taken on January 15, 2012 in Lil
FeaturesThe U.S. has a drug shortage — and people are dying
By Mark KobaJanuary 6, 2015
EyebrowJ&J starts clinical trials of Ebola drug
By ReutersJanuary 6, 2015
Key Speakers At The Stanford Institute For Economic Policy Research Forum
LeadershipStep aside Wall Street, small pharma CEO pay reaches for the sky
By Paul HodgsonJanuary 5, 2015
Health workers in protective equipment handle a sample taken from the body of someone who is suspected to have died from Ebola virus, near Rokupa Hospital
FeaturesRoche wins FDA emergency approval for Ebola test
By Laura LorenzettiDecember 29, 2014
Roche Holding AG's Headquarters As Drugmaker Acquires InterMune Inc. For $8.3 Billion
EyebrowRoche shares tumble after Alzheimer’s drug failure
By ReutersDecember 19, 2014
Inside Rite Aid Ahead of Earnings Reports
FeaturesRite Aid’s healthcare investments are paying off
By Laura LorenzettiDecember 18, 2014
FeaturesDrug-resistant infections could cost the global economy $100 trillion by 2050
By Laura LorenzettiDecember 12, 2014
Greg Wasson of Walgreen's in Chicago for Fotune 6-27-13
RetailWalgreen CEO to leave after Alliance Boots deal in reversal of plan
By Phil WahbaDecember 10, 2014
Valeant Offers to Buy Allergan With Pershing's Support
FinanceValeant puts dealmaking on hold to focus on the bottom line
By Laura LorenzettiDecember 9, 2014
FinanceMerck takes aim at superbugs with $9.5 billion deal for Cubist
By ReutersDecember 8, 2014
BRITAIN-PHARMACEUTICAL-GSK
EyebrowGSK cuts U.S. research and sales jobs as market gets tougher
By ReutersDecember 4, 2014
Images Of Over-The-Counter Medicines And Dietary Supplements By Japanese Drugmakers
FeaturesJapan’s Otsuka to buy U.S. drug maker Avanir for $3.5 billion
By Laura LorenzettiDecember 2, 2014
Las Vegas Hit By Economic Downturn
FinanceWynn Resorts under investigation for potential money laundering
By Tom Huddleston Jr.November 21, 2014
Valeant Offers to Buy Allergan With Pershing's Support
EyebrowAfter losing out over Allergan, Valeant announces $2 billion buyback
By Geoffrey SmithNovember 21, 2014
1...
  • 96
  • 97
  • 98
  • 99
  • 100
100
Most Popular
Middle East
Iran's attacks have collapsed, and the trend is 'overwhelmingly positive,' analysts say. But the military side is separate from politics and marketsAn image of a popular article
By Jason MaMarch 16, 2026
Investing
Peter Thiel is actively convincing billionaires to abandon The Giving Pledge — and it may be workingAn image of a popular article
By Jake AngeloMarch 16, 2026
Politics
'No, we didn’t': DOGE staffer admits Elon Musk’s cost-cutting agency failed to reduce the federal deficitAn image of a popular article
By Sasha RogelbergMarch 16, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.